Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

Oxaliplatin plus fluorouracil/folinic acid (5-FU/FA) every 2 weeks has shown promising activity in advanced gastric cancer. This study assessed the efficacy and safety of weekly oxaliplatin plus 5-FU/FA (FUFOX regimen) in the metastatic setting. Patients with previously untreated metastatic gastric...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lordick, F, Lorenzen, S, Stollfuss, J, Vehling-Kaiser, U, Kullmann, F, Hentrich, M, Zumschlinge, R, Dietzfelbinger, H, Thoedtmann, J, Hennig, M, Seroneit, T, Bredenkamp, R, Duyster, J, Peschel, C
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2005
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361546/
https://ncbi.nlm.nih.gov/pubmed/16012522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602697
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares